Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
all to provide the highest quality experience for your patients
Harnisch JP, et al
Women with type 2 diabetes mellitus or pre-diabetes associated with obesity/overweight (the treatment sometimes manages to reverse the metabolic alteration completely after weight loss)
In March 2026, Structure reported 44-week topline data from the ACCESS II Phase 2 study, showing placebo-adjusted weight loss of up to 16.3%, which the company described as the highest efficacy demonstrated among oral GLP-1 receptor agonists at that time point
%20copy.jpg)
US$ 26.47
US$ 25.01
US$ 27.83
